Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States

Abstract Background Two-drug regimens (2DRs) have been introduced in recent years to potentially reduce antiretroviral therapy (ART) toxicities and drug-drug interactions while demonstrating comparable efficacy to three-drug regimens (3DRs) for people with HIV (PWH). The objective of this study was...

Full description

Bibliographic Details
Main Authors: Gerald Pierone, Jennifer S. Fusco, Laurence Brunet, Vani Vannappagari, Supriya Sarkar, Cassidy E. Henegar, Jean van Wyk, Michael B. Wohlfeiler, Anthony Mills, Gregory P. Fusco
Format: Article
Language:English
Published: BMC 2024-10-01
Series:AIDS Research and Therapy
Subjects:
2-drug regimen
3-drug regimen
Antiretroviral therapy
Cohort
HIV
Effectiveness
Online Access:https://doi.org/10.1186/s12981-024-00668-7

Internet

https://doi.org/10.1186/s12981-024-00668-7

Similar Items